GPA
DGX icon

Garrison Point Advisors’s Quest Diagnostics DGX Stock Holding History

Garrison Point Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605K Hold
2,856
– – 0.25% 100
2026
Q1 		$560K Hold
2,856
– – 0.26% 101
2025
Q4 		$496K Hold
2,856
– – 0.22% 103
2025
Q3 		$544K Hold
2,856
– – 0.23% 100
2025
Q2 		$513K Hold
2,856
– – 0.24% 100
2025
Q1 		$483K Hold
2,856
– – 0.23% 102
2024
Q4 		$431K Buy
+2,856
New +$444K 0.2% 103

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Garrison Point Advisors's DGX Position: Q2 2026 in Review

Garrison Point Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2,856 shares worth $605K. The position accounts for 0.25% of the portfolio, ranked #100.

Garrison Point Advisors first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Garrison Point Advisors held 2,856 shares of Quest Diagnostics worth $605K as of Q2 2026.
  • Garrison Point Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.25% of Garrison Point Advisors's portfolio in Q2 2026, its #100 holding.
  • Garrison Point Advisors first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.